N-methyl-N'-nitro-N-nitrosoguanidine activates cell-cycle arrest through distinct mechanisms activated in a

Dillon I Beardsley1, Wan-Ju Kim, Kevin D Brown

  • 1Department of Biochemistry and Molecular Biology, University of Florida College of Medicine, Gainesville, FL 32611, USA.

Insights

High doses of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) activate the G(2) DNA damage checkpoint independently of mismatch repair (MMR) and ATM. This arrest relies on ATR and Chk1 kinases, revealing dose-dependent MNNG checkpoint activation mechanisms.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • DNA Damage Response

Background:

  • S(N)1-alkylating agents like N-methyl-N itro-N-nitrosoguanidine (MNNG) are mutagenic and cytotoxic.
  • The G(2) checkpoint is crucial for DNA damage response and cell cycle progression.

Purpose of the Study:

  • To investigate the dose-dependent mechanisms by which MNNG activates the G(2) checkpoint.
  • To elucidate the roles of mismatch repair (MMR), ATM, ATR, and Chk1 in MNNG-induced G(2) arrest.

Main Methods:

  • Treatment of cells with varying doses of MNNG.
  • Utilizing pharmacological inhibitors (caffeine, UCN-01) of checkpoint kinases.
  • Employing RNA interference to assess the function of ATR and Chk1.
  • Assessing cell-cycle arrest and inactivation of cell-cycle regulators (Cdc25C, Cdc2).

Main Results:

  • High-dose MNNG overrides the MMR-dependence for G(2) arrest.
  • High-dose MNNG activates G(2) arrest via an ATM-independent pathway.
  • ATR and Chk1, but not Chk2, are essential for high-dose MNNG-induced G(2) arrest.
  • MNNG activates the G(2) checkpoint through distinct dose-dependent mechanisms.

Conclusions:

  • MNNG's activation of the G(2) DNA damage checkpoint is dose-dependent.
  • High-dose MNNG utilizes an ATM-independent, ATR/Chk1-dependent pathway for G(2) arrest.
  • Understanding these pathways is critical for cancer therapy and mutagenicity studies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...